10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,544 | -27,292 | 180 | -34,358 | -182,627 |
| Depreciation Amortization | 43,816 | 32,530 | 19,465 | 9,814 | 43,708 |
| Accounts receivable | 41,314 | 44,546 | 37,917 | 35,325 | 26,951 |
| Accounts payable and accrued liabilities | -2,126 | 3,292 | 3,488 | -2,547 | -3,354 |
| Other Working Capital | 24,250 | 6,361 | -25,409 | 28,280 | 2,338 |
| Other Operating Activity | 72,340 | 35,836 | 16,418 | -2,163 | 119,648 |
| Operating Cash Flow | $136,050 | $95,273 | $52,059 | $34,351 | $6,664 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,765 | 1,141 | 639 | N/A | -19,238 |
| PPE Investments | -5,935 | -4,158 | -3,471 | -1,893 | -12,393 |
| Net Acquisitions | -9,268 | -8,616 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -1,000 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1,000 |
| Investing Cash Flow | $-13,438 | $-11,633 | $-2,832 | $-1,893 | $-32,631 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,803 | 4,561 | 3,944 | 422 | 10,914 |
| Financing Cash Flow | $6,803 | $4,561 | $3,944 | $422 | $10,914 |
| Exchange Rate Effect | 484 | 441 | 474 | 114 | -164 |
| Beginning Cash Position | 344,067 | 344,067 | 344,067 | 344,067 | 359,284 |
| End Cash Position | 473,966 | 432,709 | 397,712 | 377,061 | 344,067 |
| Net Cash Flow | $129,899 | $88,642 | $53,645 | $32,994 | $-15,217 |
| Free Cash Flow | |||||
| Operating Cash Flow | 136,050 | 95,273 | 52,059 | 34,351 | 6,664 |
| Capital Expenditure | -5,935 | -4,158 | -3,471 | -1,893 | -12,393 |
| Free Cash Flow | 130,115 | 91,115 | 48,588 | 32,458 | -5,729 |